HSPA1A was shown to inhibit the production of proinflammatory factors (TNF-α and IL-6) and inhibit the activity of matrix metalloprotein kinases (MMPs) and iNOS in both in vitro and in vivo models of ischemia (Belenichev et al. 2023). This evidence concerns the gene TNF and ischemia.